Vasodilator therapy of congestive heart failure.
D001022:Aortic Valve Insufficiency / Q000188:drug therapy; D002216:Captopril / Q000627:therapeutic use; D004280:Dobutamine / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D007548:Isosorbide Dinitrate / Q000627:therapeutic use; D008914:Minoxidil / Q000627:therapeutic use; D008944:Mitral Valve Insufficiency / Q000188:drug therapy; D005996:Nitroglycerin / Q000627:therapeutic use; D009599:Nitroprusside / Q000627:therapeutic use; D010646:Phentolamine / Q000627:therapeutic use; D005082:Physical Exertion; D010879:Piperazines / Q000627:therapeutic use; D011224:Prazosin / Q000627:therapeutic use; D011799:Quinazolines / Q000627:therapeutic use; D013997:Time Factors; D014665:Vasodilator Agents / Q000627:therapeutic use*
D010879:Piperazines; D011799:Quinazolines; D014665:Vasodilator Agents; D009599:Nitroprusside; D006830:Hydralazine; C005185:trimazosin; D004280:Dobutamine; D008914:Minoxidil; D002216:Captopril; D005996:Nitroglycerin; D007548:Isosorbide Dinitrate; D011224:Prazosin; D010646:Phentolamine